Abstract:Malignant tumors, including colorectal cancer (CRC), usually rely on ATP generation through aerobic glycolysis for both rapid growth and chemotherapy resistance. The M2 isoform of pyruvate kinase (PKM2) has a key role in catalyzing glycolysis, and PKM2 expression varies even within a single tumor. In this study, we confirmed that expression of PKM2 is heterogeneous in CRC cells, namely high in oxaliplatin‐resistant cells, but relatively low in sensitive cells, and found that chemoresistant cells had enhanced glycolysis and ATP production. In addition, we report a PKM2‐dependent mechanism, through which chemosensitive cells may gradually transform into chemoresistant cells.. The circular RNA hsa_circ_0005963 (termed ciRS‐122 in this study), which was determined to be a sponge for the PKM2‐targeting miR‐122, was positively correlated with chemoresistance. In vitro and in vivo studies showed that exosomes from oxaliplatin‐resistant cells delivered ciRS‐122 to sensitive cells, thereby promoting glycolysis and drug resistance through miR‐122 sponging and PKM2 upregulation. Moreover, si‐ciRS‐122 transported by exosomes could suppress glycolysis and reverse resistance to oxaliplatin by regulating the ciRS‐122 − miR‐122 − PKM2 pathway in vivo. Exosomes derived from chemoresistant CRC cells could transfer ciRS‐122 across cells and promote glycolysis to reduce drug susceptibility in chemosensitive cells. This intercellular signal delivery suggests a potential novel therapeutic target and establishes a foundation for future clinical applications in drug‐resistant CRC.

What problem does this paper attempt to address?

The problem that this paper attempts to solve is the mechanism of chemoresistance in colorectal cancer (CRC). Specifically, the researchers focused on how exosomes promote the formation of chemoresistance during the transfer of circular RNAs (circRNAs). The study found that a specific circular RNA - hsa_circ_0005963 (named ciRS - 122), up - regulates the expression of PKM2 by acting as a sponge for miR - 122, thereby enhancing the glycolytic activity of cells and leading to increased resistance to chemotherapeutic drugs (such as oxaliplatin). In addition, the study also explored the role of this mechanism in in - vivo experiments and whether inhibiting ciRS - 122 can reverse resistance. ### Main problems 1. **Molecular mechanism of chemoresistance**: The researchers attempted to reveal the specific molecular mechanism of chemoresistance in colorectal cancer, especially the role of PKM2 in this process. 2. **Exosome - mediated resistance transfer**: The researchers explored how exosomes transfer resistance signals between cells, especially by carrying specific circRNAs (such as ciRS - 122). 3. **Function of circRNA**: The researchers verified how ciRS - 122, as a sponge for miR - 122, affects the expression of PKM2, and then affects cell glycolysis and resistance. ### Research background - **Chemoresistance**: Chemoresistance is a major obstacle in cancer treatment, especially in colorectal cancer. The formation mechanism of resistance is complex and involves multiple molecules and signaling pathways. - **Role of PKM2**: PKM2 is a key enzyme in the glycolytic pathway, and its expression level is related to the metabolic activity and resistance of tumors. - **Function of exosomes**: Exosomes are nanoscale vesicles secreted by cells and can carry various biomolecules (such as RNA, proteins, etc.), and transfer signals between cells. ### Research methods - **Cell culture and transfection**: Human colorectal cancer cell lines (such as SW480 and HCT116) and their resistant strains (such as SW480/L - OHP and HCT116/L - OHP) were used, and the expressions of miR - 122, ciRS - 122 and PKM2 were regulated by transfection techniques. - **Exosome isolation and identification**: Exosomes were isolated from cell culture supernatants and sera, and identified by transmission electron microscopy (TEM), nanoparticle tracking analysis (NTA) and Western Blot techniques. - **Functional experiments**: Experiments such as CCK - 8 cell viability assay, flow cytometry, ATP measurement, glucose uptake and lactate production assay were used to evaluate the metabolic activity and resistance of cells. ### Main findings - **Heterogeneity of PKM2**: In colorectal cancer cells, the expression of PKM2 is heterogeneous, with higher expression in resistant cells and lower expression in sensitive cells. - **Regulatory role of ciRS - 122**: ciRS - 122 up - regulates the expression of PKM2 by acting as a sponge for miR - 122, thereby enhancing cell glycolytic activity and resistance. - **Exosome - mediated resistance transfer**: Exosomes derived from resistant cells can transfer ciRS - 122 to sensitive cells, resulting in enhanced glycolytic activity and increased resistance in sensitive cells. ### Conclusion This study reveals the important role of exosome - mediated circRNA (ciRS - 122) in chemoresistance in colorectal cancer, providing a theoretical basis for the development of new treatment strategies. By targeting ciRS - 122 or its downstream molecules, it may be helpful to overcome chemoresistance and improve treatment effects.

Exosome‐delivered circRNA promotes glycolysis to induce chemoresistance through the miR‐122‐PKM2 axis in colorectal cancer